Erloren Tablet 150 mg contains Erlotinib, a targeted anticancer medication used primarily in the treatment of certain types of non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib belongs to a class of drugs known as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, which work by blocking specific proteins that promote the growth and spread of cancer cells.

Cancer develops when abnormal cells grow uncontrollably and form tumors. In some cancers, particularly lung cancers with EGFR mutations, the epidermal growth factor receptor plays a significant role in stimulating tumor growth. Erloren Tablet helps slow or stop the growth of these cancer cells by interfering with the signaling pathways responsible for cell proliferation. By targeting these specific pathways, Erlotinib offers a more focused approach to cancer treatment compared with traditional chemotherapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each tablet contains:

• Erlotinib 150 mg

Mechanism of Action

Erlotinib works by inhibiting the activity of the epidermal growth factor receptor (EGFR), a protein found on the surface of certain cancer cells. EGFR is involved in the signaling process that regulates cell growth and division.

By blocking EGFR tyrosine kinase activity, Erlotinib:

• Prevents cancer cells from receiving growth signals

• Slows or stops tumor cell proliferation

• Helps reduce the spread of cancer cells to other parts of the body

• May contribute to tumor shrinkage in responsive cancers

This targeted mechanism makes Erlotinib an important therapy in cancers where EGFR signaling plays a key role.

Indications

Erloren Tablet 150 mg is indicated for the treatment of:

• Non-small cell lung cancer (NSCLC), particularly in patients with EGFR mutations

• Locally advanced or metastatic pancreatic cancer, usually in combination with other therapies

• Maintenance therapy in certain lung cancer patients after initial treatment

• Patients whose cancer has progressed following chemotherapy

Treatment is typically prescribed and monitored by oncology specialists.

Dosage and Administration

The dosage of Erloren Tablet should be determined by a qualified physician, depending on the type of cancer, stage of the disease, and the patient’s overall health.

General usage guidelines include:

• Usually taken once daily

• Should be taken on an empty stomach (at least 1 hour before or 2 hours after food)

• Swallow the tablet whole with water

• Follow the exact dosing schedule recommended by the doctor

Regular medical monitoring and laboratory tests may be required during treatment.

Precautions

Before taking Erloren Tablet, patients should inform their doctor if they:

• Have liver or kidney disease

• Have lung problems or breathing disorders

• Are taking medications that may interact with Erlotinib

• Are pregnant or planning to become pregnant

• Are breastfeeding

Smoking may reduce the effectiveness of Erlotinib, so patients are generally advised not to smoke during treatment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Like other anticancer medicines, Erloren Tablet may cause side effects. However, not all patients experience them.

Common side effects may include:

• Skin rash

• Diarrhea

• Fatigue

• Loss of appetite

• Nausea

Less common but serious side effects may include severe skin reactions, lung inflammation (interstitial lung disease), liver problems, or severe diarrhea leading to dehydration. Patients should contact their healthcare provider if severe or persistent symptoms occur.

Storage

• Store below 25°C in a cool and dry place

• Protect from light and moisture

• Keep out of reach of children

Erloren Tablet 150 mg is an important targeted therapy for certain cancers, helping slow tumor growth and improve treatment outcomes when used under the supervision of a qualified healthcare professional.